What is Abraxane (Paclitaxel)
ABRAXANE is a prescription medicine used to treat:
• advanced breast cancer in people who have already received certain other medicines for their cancer. • advanced non-small cell lung cancer, in combination with carboplatin in people who cannot be treated with surgery or radiation.
• and advanced pancreatic cancer, when used in combination with gemcitabine as the first medicine for advanced pancreatic cancer. It is not known if ABRAXANE is safe or effective in children.
ABRAXANE is a microtubule inhibitor indicated for the treatment of:
Metastatic breast cancer,after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin,in patients who are not candidates for curative surgery or radiation therapy.
Metastatic adenocarcinoma of the pancreasasfirst-line treatment,in combination with gemcitabine
100 mg of paclitaxel in a single – use vial.
Storage and handling:
Store the vials in original cartons at 20 º C to 25 º C (68 º F to 77 º F). Retain in the original package to protect from bright light.
How do we source the Drug?
SSPWL sources its drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
M/s Abraxis BioScience, LLC.
Assistance Cell in India:
For ONCOLOGY DRUG: Abraxane (Paclitaxel) price.
Call: +91 07738100125 / +91 07738151650 or